Cellular Microenvironment Stiffness Regulates Eicosanoid Production and Signaling Pathways.


Journal

American journal of respiratory cell and molecular biology
ISSN: 1535-4989
Titre abrégé: Am J Respir Cell Mol Biol
Pays: United States
ID NLM: 8917225

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 15 9 2020
medline: 8 1 2021
entrez: 14 9 2020
Statut: ppublish

Résumé

Pathological changes in the biomechanical environment are implicated in the progression of idiopathic pulmonary fibrosis (IPF). Stiffened matrix augments fibroblast proliferation and differentiation and activates TGF-β1 (transforming growth factor-β1). Stiffened matrix impairs the synthesis of the antifibrogenic lipid mediator prostaglandin E

Identifiants

pubmed: 32926636
doi: 10.1165/rcmb.2020-0227OC
doi:

Substances chimiques

Imidazoles 0
Pyridines 0
Cyclooxygenase 2 EC 1.14.99.1
Prostaglandin-E Synthases EC 5.3.99.3
Dinoprostone K7Q1JQR04M
SB 203580 OU13V1EYWQ

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

819-830

Commentaires et corrections

Type : CommentIn

Auteurs

Asres Berhan (A)

Department of Pharmacology and Therapeutics, and.

Trudi Harris (T)

Department of Pharmacology and Therapeutics, and.

Jade Jaffar (J)

Department of Allergy, Immunology, Respiratory Medicine, The Alfred Hospital/Monash University, Melbourne, Victoria, Australia.

Fernando Jativa (F)

Department of Pharmacology and Therapeutics, and.
Department of Biomedical Engineering, University of Melbourne, Parkville, Victoria, Australia.

Shenna Langenbach (S)

Department of Pharmacology and Therapeutics, and.

Ingrid Lönnstedt (I)

CSL Ltd., Melbourne, Victoria, Australia; and.

Monther Alhamdoosh (M)

CSL Ltd., Melbourne, Victoria, Australia; and.

Milica Ng (M)

CSL Ltd., Melbourne, Victoria, Australia; and.

Peter Lee (P)

Department of Biomedical Engineering, University of Melbourne, Parkville, Victoria, Australia.

Glen Westall (G)

Department of Allergy, Immunology, Respiratory Medicine, The Alfred Hospital/Monash University, Melbourne, Victoria, Australia.

Nick Wilson (N)

CSL Ltd., Melbourne, Victoria, Australia; and.

Michael Wilson (M)

CSL Ltd., Melbourne, Victoria, Australia; and.

Alastair G Stewart (AG)

Department of Pharmacology and Therapeutics, and.
ARC Centre for Personalised Therapeutics Technologies, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH